Norway - Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung
Since 2014, Norway Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung decreased by 2.2% year on year. In 2019, the country was ranked number 31 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung at 6.1 Days. Norway is overtaken by Denmark, which was number 30 with 6.2 Days and is followed by Mexico at 5.6 Days. Costa Rica lead the ranking with 14.1 Days in 2019, a growth of 6.8% compared to 2018. South Korea, Portugal and Ireland respectively ranked number 2, 3 and 4 in this ranking. Costa Rica recorded the best 5 years average growth at +2.8% per year, while Mexico witnessed the worst performance at -6.2% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.10 |
| 2018 | 5.90 |
| 2017 | 6.10 |
| 2016 | 6.20 |
| 2015 | 6.80 |
How does Norway rank in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Costa Rica
|
14.10 | 2019 | +6.8 % | +2.8 % | View data | |
| 2 |
#2
South Korea
|
13.70 | 2019 | -0.7 % | -0.1 % | View data | |
| 30 |
#30
Denmark
|
6.20 | 2019 | -1.6 % | -1.8 % | View data | |
| 31 |
#31
Norway
|
6.10 | 2019 | +3.4 % | -2.1 % | View data | |
| 32 |
#32
Mexico
|
5.60 | 2019 | -5.1 % | -6.2 % | View data | |